Tag: Abivax

French biotech stock soars 34% after new data on experimental medicine

Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease, clawing back heavy losses from earlier in the month when the same trial had investors questioning the drug’s future.